Q: What is Myfembree used for?

Myfembree is used to treat heavy menstrual bleeding associated with uterine fibroids , as well as moderate to severe pain associated with endometriosis .

Q: How does Myfembree work?

Mechanism of Action Myfembree is a combination of three medications that work together to treat symptoms of uterine fibroids and endometriosis. It targets the hormonal triggers that cause these conditions to progress. Hormone Suppression The primary ingredient, relugolix, is a gonadotropin-releasing hormone (GnRH) receptor antagonist. It blocks the pituitary gland from releasing the hormones that signal the ovaries to produce estrogen and progesterone. By significantly lowering these hormone levels, the medication helps to: Reduce the heavy menstrual bleeding caused by uterine fibroids. Decrease the growth of endometrial tissue, which reduces pelvic pain. Hormonal Balance Because suppressing estrogen can lead to side effects like bone thinning and hot flashes, Myfembree includes estradiol and norethindrone acetate. These components provide a small amount of add-back hormone therapy. This helps maintain bone density and manage menopausal-like symptoms while the relugolix continues to treat the underlying condition.

Q: What are the active ingredients in Myfembree?

The active ingredients in Myfembree are relugolix , estradiol , and norethindrone .

Q: What are the side effects of Myfembree?

Common side effects of Myfembree may include: Hot flashes Headache Nausea Always consult with a healthcare professional about potential side effects.

Q: What drug class is Myfembree?

Myfembree belongs to the GnRH receptor antagonist combination drug class.

Q: What is the dosage of Myfembree and how do I take it?

How to Take Myfembree This medication is taken by mouth once a day. It should be swallowed whole and can be taken with or without food. To help maintain consistent levels in your body, try to take it at the same time every day. Starting Treatment Healthcare providers usually recommend starting this medication within the first seven days after your menstrual period begins. If you are switching from another hormonal contraceptive, follow your doctor's specific instructions on when to begin the first dose. Missed Dose If you miss a dose, take it as soon as you remember on the same day. If you do not remember until the next day, skip the missed dose entirely and take your next dose at the regular time. Do not take two doses at once to make up for a missed one. Duration of Use Because long-term use of this medication can lead to a decrease in bone mineral density, treatment is generally limited to a total duration of 24 months.

Q: Is Myfembree safe during pregnancy and breastfeeding?

Pregnancy Myfembree is contraindicated for use during pregnancy because it may cause harm to a developing fetus or lead to early pregnancy loss (miscarriage). Although this medication can change or stop menstrual periods, it is not a form of birth control. It is important to use effective non-hormonal contraception, such as condoms or a copper IUD, while taking Myfembree and for at least one week after the final dose. If you suspect you are pregnant, you should stop taking the medication immediately and contact a healthcare provider. Breastfeeding It is not known if the components of Myfembree pass into human breast milk or how they might affect a nursing infant. Because of the potential for serious adverse reactions in a breastfed child, breastfeeding is generally not recommended during treatment with this medication. Patients should discuss the risks and benefits of breastfeeding with their healthcare team to determine the safest approach for their situation.

Q: What is the FDA approval status of Myfembree?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) has approved Myfembree for use in premenopausal women for the following indications: Management of heavy menstrual bleeding associated with uterine fibroids. Management of moderate to severe pain associated with endometriosis. Boxed Warning Myfembree carries a boxed warning concerning the risk of thromboembolic disorders and vascular events, such as stroke, heart attack, and blood clots. These risks are increased in women who smoke, are over 35 years of age, or have uncontrolled high blood pressure. The medication is contraindicated in women with a history of or high risk for blood clots, certain types of cancer, or undiagnosed abnormal uterine bleeding. Usage Limitations Due to the risk of bone mineral density loss, which may not be fully reversible, the FDA recommends that the use of Myfembree be limited to a total duration of 24 months. Regulatory Status Myfembree is available only by prescription. There are currently no FDA-approved generic versions of this medication available in the United States. It is not a controlled substance.

Question 1

What is Myfembree?

Accepted Answer

Myfembree is a combination medication containing relugolix, estradiol, and norethindrone acetate. It works by modulating the body's hormonal signals, specifically targeting the production of estrogen in the ovaries.

The therapy utilizes a gonadotropin-releasing hormone (GnRH) receptor antagonist alongside supplemental estrogen and progestin. This combination is designed to regulate hormonal activity and maintain a stable physiological environment.

Question 2

What is Myfembree used for?

Accepted Answer

Myfembree is used to treat heavy menstrual bleeding associated with uterine fibroids, as well as moderate to severe pain associated with endometriosis.

Question 3

How does Myfembree work?

Accepted Answer

Mechanism of Action

Myfembree is a combination of three medications that work together to treat symptoms of uterine fibroids and endometriosis. It targets the hormonal triggers that cause these conditions to progress.

Hormone Suppression

The primary ingredient, relugolix, is a gonadotropin-releasing hormone (GnRH) receptor antagonist. It blocks the pituitary gland from releasing the hormones that signal the ovaries to produce estrogen and progesterone. By significantly lowering these hormone levels, the medication helps to:

Reduce the heavy menstrual bleeding caused by uterine fibroids.
Decrease the growth of endometrial tissue, which reduces pelvic pain.

Hormonal Balance

Because suppressing estrogen can lead to side effects like bone thinning and hot flashes, Myfembree includes estradiol and norethindrone acetate. These components provide a small amount of add-back hormone therapy. This helps maintain bone density and manage menopausal-like symptoms while the relugolix continues to treat the underlying condition.

Question 4

What are the active ingredients in Myfembree?

Accepted Answer

The active ingredients in Myfembree are relugolix, estradiol, and norethindrone.

Question 5

What are the side effects of Myfembree?

Accepted Answer

Common side effects of Myfembree may include:

Hot flashes
Headache
Nausea

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Myfembree?

Accepted Answer

Myfembree belongs to the GnRH receptor antagonist combination drug class.

Question 7

What is the dosage of Myfembree and how do I take it?

Accepted Answer

How to Take Myfembree

This medication is taken by mouth once a day. It should be swallowed whole and can be taken with or without food. To help maintain consistent levels in your body, try to take it at the same time every day.

Starting Treatment

Healthcare providers usually recommend starting this medication within the first seven days after your menstrual period begins. If you are switching from another hormonal contraceptive, follow your doctor's specific instructions on when to begin the first dose.

Missed Dose

If you miss a dose, take it as soon as you remember on the same day. If you do not remember until the next day, skip the missed dose entirely and take your next dose at the regular time. Do not take two doses at once to make up for a missed one.

Duration of Use

Because long-term use of this medication can lead to a decrease in bone mineral density, treatment is generally limited to a total duration of 24 months.

Question 8

Is Myfembree safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Myfembree is contraindicated for use during pregnancy because it may cause harm to a developing fetus or lead to early pregnancy loss (miscarriage). Although this medication can change or stop menstrual periods, it is not a form of birth control. It is important to use effective non-hormonal contraception, such as condoms or a copper IUD, while taking Myfembree and for at least one week after the final dose. If you suspect you are pregnant, you should stop taking the medication immediately and contact a healthcare provider.

Breastfeeding

It is not known if the components of Myfembree pass into human breast milk or how they might affect a nursing infant. Because of the potential for serious adverse reactions in a breastfed child, breastfeeding is generally not recommended during treatment with this medication. Patients should discuss the risks and benefits of breastfeeding with their healthcare team to determine the safest approach for their situation.

Question 9

What forms and strengths does Myfembree come in?

Accepted Answer

Myfembree is supplied as a film-coated tablet for oral administration. This medication is a fixed-dose combination product containing relugolix, estradiol, and norethindrone acetate.

Oral tablet

Question 10

What is the FDA approval status of Myfembree?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) has approved Myfembree for use in premenopausal women for the following indications:

Management of heavy menstrual bleeding associated with uterine fibroids.
Management of moderate to severe pain associated with endometriosis.

Boxed Warning

Myfembree carries a boxed warning concerning the risk of thromboembolic disorders and vascular events, such as stroke, heart attack, and blood clots. These risks are increased in women who smoke, are over 35 years of age, or have uncontrolled high blood pressure.

The medication is contraindicated in women with a history of or high risk for blood clots, certain types of cancer, or undiagnosed abnormal uterine bleeding.

Usage Limitations

Due to the risk of bone mineral density loss, which may not be fully reversible, the FDA recommends that the use of Myfembree be limited to a total duration of 24 months.

Regulatory Status

Myfembree is available only by prescription. There are currently no FDA-approved generic versions of this medication available in the United States. It is not a controlled substance.

Question 11

What should I know about Myfembree and cost?

Accepted Answer

Insurance and Pharmacy Costs

The amount you pay for Myfembree is primarily determined by your health insurance plan. Factors such as your deductible, copayment, and whether the drug is on your plan's preferred list (formulary) will influence the final price. Costs can also vary between different pharmacies.

Generic Status

There is currently no generic equivalent for Myfembree. Because it is a brand-name medication, it may be more expensive than older treatments. Generic versions are usually not available until several years after a drug is first approved by the FDA.

Financial Support Options

The manufacturer of Myfembree may offer a savings card or support program to help reduce out-of-pocket expenses for eligible patients with commercial insurance. For those without insurance or with limited coverage, patient assistance programs may be available to provide the medication at a lower cost or for free, depending on financial need.

Myfembree

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Myfembree

Hospitals.net Disclosure